Caep Centro Avancado de Estudos E Pesquisas Ltda
Campinas, SP, Brazil
Laboratory in Campinas, State of São Paulo
R. José Geraldo Cerebino Christófaro, 245 - Fazenda Santa Cândida, Campinas - SP, 13087-567
About Caep Centro Avancado de Estudos E Pesquisas Ltda
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Pfizer
3
EMS
2
Genentech, Inc.
2
Hoffmann-La Roche
2
Clinical Trials at Caep Centro Avancado de Estudos E Pesquisas Ltda
During the past decade, Caep Centro Avancado de Estudos E Pesquisas Ltda conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 10 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes
2012-07-01
2015-03-01
Completed
150
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
2014-05-21
2020-04-16
Completed
609
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
2016-09-09
2018-07-02
Completed
578
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Caep Centro Avancado de Estudos E Pesquisas Ltda" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "EMS" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Caep Centro Avancado de Estudos E Pesquisas Ltda"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Luxbiotech" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Caep Centro Avancado de Estudos E Pesquisas Ltda
According to Clinical.Site data, the most researched conditions in "Caep Centro Avancado de Estudos E Pesquisas Ltda" are
"Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Rheumatoid Arthritis" (2 trials), "Ulcerative Colitis" (2 trials) and "Chronic Telogen Effluvium" (1 trials). Many other conditions were trialed in "Caep Centro Avancado de Estudos E Pesquisas Ltda" in a lesser frequency.
Clinical Trials Intervention Types at Caep Centro Avancado de Estudos E Pesquisas Ltda
Most popular intervention types in "Caep Centro Avancado de Estudos E Pesquisas Ltda" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "GDC-0853" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Aciclovir" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Caep Centro Avancado de Estudos E Pesquisas Ltda
The vast majority of trials in "Caep Centro Avancado de Estudos E Pesquisas Ltda" are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Caep Centro Avancado de Estudos E Pesquisas Ltda
Currently, there are NaN active trials in "Caep Centro Avancado de Estudos E Pesquisas Ltda".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Caep Centro Avancado de Estudos E Pesquisas Ltda,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Caep Centro Avancado de Estudos E Pesquisas Ltda, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".